Magnesium phosphate

Molecular mass: 262.858 g/mol 

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
B05XA10 Magnesium phosphate B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives → B05XA Electrolyte solutions
Discover more medicines within B05XA10

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 7757-87-1
DrugBank Drug: DB13862
RxNorm Ingredient: 29164
SNOMED-CT Concept: 31731008
Magnesium phosphate (substance)
UNII Identifier: XMK14ETW2D
MAGNESIUM PHOSPHATE ANHYDROUS

Medicines

Magnesium phosphate is an active ingredient of these brands:

Malta (MT)

  • NEOMAG as Magnesium glycerophosphate

New Zealand (NZ)

Tunisia (TN)

  • (combination) UVIMAG B6 as Magnesium glycerophosphate

United Kingdom (UK)

  • NEOMAG as Magnesium glycerophosphate

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈